Explore Global Companies & Account Intelligence

.

Anant Raj Group is one of the leading Construction and Infrastructure Developers in North India.

Ananya Finance for Inclusive Growth Pvt. Ltd. (Ananya) is an NBFC set up by Friends of Women’s World Banking – India (FWWB) in 2009, with the objective of reaching out to a large section of microfinance institutions (MFIs) and grass root entities. Ananya is among the most responsible NBFCs in India with the urge and commitment to serve socially motivated double bottom-line enterprises. Ananya started operations by taking over FWWB’s Wholesale Microfinance Institution lending portfolio in April, 2010. The NBFC has come a long way, facing the Andhra Pradesh Microfinance crisis in its year of birth, in 2010, surviving the financially challenging 4 years that followed the crisis and started to turn around in the year 2015 when it registered full year net profits. The company has been steadily regaining its momentum since FY 2015-16 and achieved the important milestone of its portfolio crossing Rs.100 Crore during the previous FY 2017-18. The company ended the financial year in March, 2018 with a loan portfolio of Rs.152 Crore. Ananya has a robust lending portfolio today diversified across Microfinance and Agribusiness segments. In the MFI space, Ananya has, in the past, served a good majority of the now-large-sized MFIs and SFBs, including Bandhan, Janalakshmi, Ujjivan and Suryoday. Currently, Ananya’s Microfinance portfolio is well diversified across large, mid-sized and small-sized MFI partners. In Agribusiness, Ananya has had a repeat customer base of over 50%. On the borrowing side, Ananya has built a funder base well diversified across banks, financial institutions, and NBFCs. Despite being a for-profit organization, Ananya, at the core, continues to remain impact-focused. Ananya intends to lift those, who are deprived from the sufficient economic resources and environment necessary to be a part of the growth of the economy, and holistically improve their living standards. Ananya aims to do this by playing the sector-building role in the sectors aforementioned.

Ananya perceives jewellery as a talisman with energy and the ability to enhance one’s life, transcend its perception as purely material. Designer Ananya Malhotra's fascination with crystal healing, gemstone energies and Indian philosophies coupled with her love of fine and rare Indian jewellery gave birth to her namesake brand. Her experience of jewellery was more than a collection of objects, rather a symbol that resonates energy and meaning from a life deep within.

Anap Business Jets Limited (Anap Jets) is a private jet operator that specialises in fractional ownership, charter services, and aircraft management. We provide a relevant, appropriate and long-term private aviation business solution. At Anap Jets, our fractional ownership platform is designed to be financially prudent whilst allowing our clientele to retain all the essential benefits of exclusive business jet ownership. For the occasional travellers whose flying needs fluctuate, we offer ad-hoc charter flights. Our fleet is comprised of the Embraer Phenom 300 and Legacy 600 aircrafts. The Phenom 300 was the most delivered jet amongst ALL business jets globally for four consecutive years - 2013, 2014, 2015 and 2016. It is ideally suited for business travel within our region. The Embraer Legacy 600 is a much larger aircraft, which gives us the operational capability to handle both larger travelling parties (up to 13 passengers) and longer-range travel all over Africa and to Europe, South America and the Middle East (up to 3,400 nautical miles or 6,297 kilometres) without having to refuel. Our maintenance platform delivers impeccable standards and is operated in conjunction with Embraer- the aircraft manufacturer, Pratt & Whitney – the engine manufacturer for the Phenom 300s, Rolls Royce – the engine manufacturer for the Legacy 600, and Eurofly Service S.p.A. – our Technical Partners. Together with the Approved Service Centre in Lagos, Anap Jets’ maintenance partners offer combined institutional experience in excess of 100 years. More information on Anap Jets is available at www.anapjets.com.

Anap Business Jets Limited (Anap Jets) is a private jet operator that specialises in fractional ownership, charter services, and aircraft management. We provide a relevant, appropriate and long-term private aviation business solution. At Anap Jets, our fractional ownership platform is designed to be financially prudent whilst allowing our clientele to retain all the essential benefits of exclusive business jet ownership. For the occasional travellers whose flying needs fluctuate, we offer ad-hoc charter flights. Our fleet is comprised of the Embraer Phenom 300 and Legacy 600 aircrafts. The Phenom 300 was the most delivered jet amongst ALL business jets globally for four consecutive years - 2013, 2014, 2015 and 2016. It is ideally suited for business travel within our region. The Embraer Legacy 600 is a much larger aircraft, which gives us the operational capability to handle both larger travelling parties (up to 13 passengers) and longer-range travel all over Africa and to Europe, South America and the Middle East (up to 3,400 nautical miles or 6,297 kilometres) without having to refuel. Our maintenance platform delivers impeccable standards and is operated in conjunction with Embraer- the aircraft manufacturer, Pratt & Whitney – the engine manufacturer for the Phenom 300s, Rolls Royce – the engine manufacturer for the Legacy 600, and Eurofly Service S.p.A. – our Technical Partners. Together with the Approved Service Centre in Lagos, Anap Jets’ maintenance partners offer combined institutional experience in excess of 100 years. More information on Anap Jets is available at www.anapjets.com.

AnaPath, is a global company including contract research organization (CRO) and pathology services that provides R&D services in the preclinical and bioanalytical fields. AnaPath is formed by two main sections: AnaPath Services, based in Switzerland and focused on pathology, and AnaPath Research, based on Barcelona and focused in preclinical development. AnaPath Services emanates from RCC/Harlan and was established in 2013. It is located close to the pharmaceutical capital Basel and has a surprisingly wide experience for a young company due to company due to its history. AnaPath Services is recognized for the scientific competence in toxicologic pathology, high operational speed and reliability. The current AnaPath Research was founded in 1980, as CIDASAL, the site had been part of multiple international companies such as RCC, Harlan and Envigo , always providing high quality services to our sponsors. In the late 2019, AnaPath services acquire the site and started a journey to the excellence of research. AnaPath is structured in departments according to the field of the services we offer, and in perfect coordination. General Toxicology performs a full range of studies to support the pharmaceutical, chemical, agrochemical and veterinary industries. The studies are performed to fulfill global regulatory guidelines in accordance with GLP (Good Laboratory Practices).

We’ve been supporting people living with serious allergies as a charity for nearly 30 years, offering information and support for individuals and their families, for businesses and for schools and other places of education. We provide resources for people with serious allergies that can be trusted and are both scientifically based and factually accurate. Most of what we offer is without charge and we rely on the generosity of our supporters to carry out our work. Our ultimate aim is to create a safe environment for all people with allergies by educating the food industry, schools, pre-schools, colleges, health professionals and other key audiences. Our focus is on medical facts, food labelling, risk reduction and allergen management. The AllergyWise online training programmes, developed by Anaphylaxis UK, provide information and support for families, carers and individuals as well as for health professionals. Anaphylaxis UK provides tailored services for individual and clinical professionals and also has a corporate membership programme.

At Anapi, we’re on a mission to help investors, startups and entrepreneurs get the protection and advice they need against their evolving business risks, so they can have the peace of mind to grow their business.

ANAPIX medical est une jeune société spécialisée dans l'imagerie de la peau en temps réel pour les dermatologues, les professionnels de santé et les entreprises. Nos missions ? Accompagner les dermatologues, optimiser la coordination interprofessionnelle, et organiser des campagnes de prévention et de détection des cancers de la peau.

Há mais de 20 anos nós atendemos incorporadoras, loteadoras e urbanizadoras, com uma tecnologia líder, cujo o objetivo é proporcionar um ambiente de negócios transparente, eficiente, seguro e dinâmico, conectando você na jornada de compra do seu cliente de ponta a ponta. Conquistamos mais de 400 incorporadoras e 262 mil usuários que utilizam nossa plataforma para gerenciar o processo completo de CRM, vendas e marketing. Durante 15 anos, já ajudamos a realizar muitos negócios. Confira nossos números:   62,45 BI VGV 2.415 EMPREENDIMENTOS 426.147 UNIDADES 130.363 CORRETORES 2,10 MI NEGÓCIOS 2,29 MI PROSPECTS Em 2019, a ANAPRO foi adquirida pela OLX, visando a liderança como plataforma de imóveis no Brasil. Com sede em São Paulo, hoje a ANAPRO tem mais de 300 incorporadoras como clientes.

ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary protein assays help assess the toxicity of molecules under development, from cellular model, animal model or patient sample.